Evaluation of Mental Flexibility Through Language Tests in Adolescents With Frontal Brain Damage and in Healthy Children in Ages 8-17

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01696292
First received: September 27, 2012
Last updated: September 28, 2012
Last verified: September 2012
  Purpose

This study aims to shed light on the theoretical concept of mental flexibility and its manifestation in adolescents following frontal lobe damage, and to develop a test battery for young Hebrew speakers.


Condition
Persons With Frontal Lobe Damage With no Specific Language Disorder

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Enrollment: 20
Study Start Date: August 2004
Study Completion Date: March 2010
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   8 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

A group of children ages 8-17 with frontal lobe damage, who are treated at the children rehabilitation center at sheba medical center

Criteria

Inclusion Criteria:

  • frontal lobe damage
  • at least one year after injury
  • native hebrew speaker

Exclusion Criteria:

  • specific language disorder
  • premorbid learning disability
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01696292

Locations
Israel
Children Rehabilitation Department Sheba Medical Center
Ramat Gan, Israel
Sponsors and Collaborators
Sheba Medical Center
  More Information

No publications provided

Responsible Party: Sheba Medical Center
ClinicalTrials.gov Identifier: NCT01696292     History of Changes
Other Study ID Numbers: SHEBA-04-3435-JL-CTIL
Study First Received: September 27, 2012
Last Updated: September 28, 2012
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Language Disorders
Communication Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on April 22, 2014